- SAMIL ESG
- Environmental Safety
- Labour and Human Rights
- Mutual Cooperation
- Social Contribution
- Ethical management
- Board of Directors
Board of Directors
The Board of Directors at Samil Pharmaceutical diligently fulfills its responsibilities in compliance with relevant laws, regulations, and the Company’s Articles of Incorporation. The Board is tasked with making key management decisions and effectively overseeing management and directors to act in the best interests of the Company and its shareholders.
Board of Directors
| Name | Experience | Date Appointed | Term | Position |
|---|---|---|---|---|
| SeungBum Huh |
|
2022.03.25 | 3 years |
CEO (Full-time) |
| YuSeok Shin |
|
2025.03.25 | 3 years |
Internal Director (Full-time) |
| TaeKeun Kwon |
|
2023.03.24 | 3 years |
Internal Director (Full-time) |
| JoonBeom Huh |
|
2025.03.25 | 3 years |
Internal Director (Full-time) |
| HyungSeok Choi |
|
2023.03.24 | 3 years |
External Director (Part-time) |
| ChangHo Kim |
|
2025.03.25 | 3 years |
External Director (Part-time) |
| HyungWook Kim |
|
2023.03.24 | 3 years |
External Director (Part-time) |
Committee within the BOD (Audit Committee)
| Classification | Name | Date Appointed | Term | Remarks |
|---|---|---|---|---|
| Audit committee members | HyungSeok Choi | 2023.03.24 | 3 years | External Director |
| ChangHo Kim | 2025.03.25 | 3 years |
External Director (Finance and accounting professional) |
|
| HyungWook Kim | 2023.03.24 | 3 years | External Director |
Current Audit Committee Composition
| Classification | Name | Date Appointed | Term | Experience | Remarks |
|---|---|---|---|---|---|
| Audit committee members | HyungSeok Choi | 2023.03.24 | 3 years |
|
External Director |
| ChangHo Kim | 2025.03.25 | 3 years |
|
External Director | |
| HyungWook Kim | 2025.03.25 | 3 years |
|
External Director |
Audit Opinion for the Last 3 Business Years
| Business Year | Auditors | Audit Opinion | Remarks |
|---|---|---|---|
| 2024 | BakerTilly | Adequate | |
| 2023 | EY | Adequate | |
| 2022 | EY | Adequate |
Voting Rights Overview (as of 2024.12.31)
| Classification | Shares | # of Shares | Remarks |
|---|---|---|---|
| Outstanding Shares(A) | Common Shares | 21,691,811 | - |
| Preferred Shares | - | - | |
| Non-Voting Shares(B) | Common Shares | 462,158 | Treasury Shares |
| Preferred Shares | - | - | |
| Shares excluded from exercising voting rights under the Articles of Incorporation(C) | Common Shares | - | - |
| Preferred Shares | - | - | |
| Shares with voting rights restricted by other laws(D) | Common Shares | - | - |
| Preferred Shares | - | - | |
| Shares with voting rights restored(E) | Common Shares | - | - |
| Preferred Shares | - | - | |
| Shares with voting rights(F = A - B - C - D + E) | Common Shares | 21,229,653 | - |
| Preferred Shares | - | - |
Adoption of E-voting, Voting in writing, and Cumulative voting
| Classification | Adopted/Not adopted |
|---|---|
| E-voting and e-proxy | Not adopted |
| Voting in writing | Not adopted |
| Cumulative voting | Not adopted |
Shareholders' Meeting Agenda and Resolutions (Date: 2025.3.21)
| Agenda | Classification | Resolution classification | Approved/Not approved | # of voting rights | # of Shares For (Percentage) | # of Shares Against/Abstained (Percentage) | |
|---|---|---|---|---|---|---|---|
| Agenda #1 | Approval of the financial statements and consolidated financial statements for the 72st period (January 1, 2024 to December 31, 2024) | Ordinary | Approved | 7,569,549 | 7,569,549 (100.00%) |
- (0.00%) |
|
|
Agenda #2
|
Partial amendment to the articles of incorporation
|
Article 3 (Installation of the location, branch, etc. of the head office) | Special | Approved | 7,569,549 | 7,468,828 (98.70%) |
100,721 (1.30%) |
| Article 7-2 (Number and Details of Preferred Shares) | Special | Approved | 7,569,549 | 7,468,828 (98.70%) |
100,721 (1.30%) |
||
| Article 7-3 (Number and Details of Repayment Shares) | Special | Approved | 7,569,549 | 7,248,593 (95.80%) |
320,956 (4.20%) |
||
| Article 7-4 (Number and Details of Convertible Shares) | Special | Approved | 7,569,549 | 7,248,593 (95.80%) |
320,956 (4.20%) |
||
| Article 9-3 (equal dividend) | Special | Approved | 7,569,549 | 7,468,828 (98.70%) |
100,721 (1.30%) |
||
| Article 14-2 (Issuance and allocation of convertible bonds) | Special | Approved | 7,569,549 | 7,248,593 (95.80%) |
320,956 (4.20%) |
||
| Article 15-1 (Issuance and allocation of bonds with underwriting rights) | Special | Approved | 7,569,549 | 7,248,593 (95.80%) |
320,956 (4.20%) |
||
| Article 15-2 (Electronic Registration of Rights to be Indicated in Bonds and Underwriting Securities) | Special | Approved | 7,569,549 | 7,468,828 (98.70%) |
100,721 (1.30%) |
||
| Article 18 (Convencing Right Holder) | Special | Approved | 7,569,549 | 7,468,828 (98.70%) |
100,721 (1.30%) |
||
| Article 21 (Chairman of the General Meeting of Shareholders) | Special | Approved | 7,569,549 | 7,468,828 (98.70%) |
100,721 (1.30%) |
||
| Article 26 (Exercise of Voting Rights) | Special | Approved | 7,569,549 | 7,468,828 (98.70%) |
100,721 (1.30%) |
||
| Article 27 (Method of Resolution at General Shareholders' Meeting) | Special | Approved | 7,569,549 | 7,248,593 (95.80%) |
320,956 (4.20%) |
||
| Article 34-1 (Duties of Directors) | Special | Approved | 7,569,549 | 7,468,828 (98.70%) |
100,721 (1.30%) |
||
| Article 34-2 (Deleted) | Special | Approved | 7,569,549 | 7,468,828 (98.70%) |
100,721 (1.30%) |
||
| Article 36 (Method of Resolution by Board of Directors) | Special | Approved | 7,569,549 | 7,468,828 (98.70%) |
100,721 (1.30%) |
||
| Article 41-2 (Appointment of External Auditors) | Special | Approved | 7,569,549 | 7,468,828 (98.70%) |
100,721 (1.30%) |
||
| Supplementary Provisions | Special | Approved | 7,569,549 | 7,248,593 (95.80%) |
320,956 (4.20%) |
||
|
Agenda #3
|
Appointment of directors
|
Agenda 3-1 Appointment of internal directors (Candidate: SeungBum Huh) | Ordinary | Approved | 7,569,549 | 7,569,539 (99.90%) |
10 (0.10%) |
| Agenda 3-2 Appointment of internal directors (Candidate: JoonBeom Huh) | Ordinary | Approved | 7,569,549 | 7,569,539 (99.90%) |
10 (0.10%) |
||
| Agenda 3-3 Appointment of internal directors (Candidate: YuSeok Shin) | Ordinary | Approved | 7,569,549 | 7,569,539 (99.90%) |
10 (0.10%) |
||
| Agenda 3-4 Appointment of External directors (Candidate: ChangHo Kim) | Ordinary | Approved | 7,569,549 | 7,349,304 (97.10%) |
220,245 (2.90%) |
||
| Agenda #4 | Appointment of external director HyungWook Kim to become an Audit Committee member | Ordinary | Approved | 5,721,498 | 5,400,542 (94.40%) |
320,956 (5.60%) |
|
| Agenda #5 | Appointment of Changho Kim as a member of the Audit Committee | Ordinary | Approved | 5,721,498 | 5,501,253 (96.20%) |
220,245 (3.80%) |
|
| Agenda #6 | Determination of the limit on director compensation payments | Ordinary | Approved | 7,569,549 | 7,468,828 (98.70%) |
100,721 (1.30%) |
|
